|  | Ghosh, Arun K. (Hrsg.)
Aspartic Acid Proteases as Therapeutic Targets
Methods and Principles in Medicinal Chemistry (Band 45)
Herausgegeben von Mannhold, Raimund / Kubinyi, Hugo / Folkers, Gerd
 1. Auflage - August 2010
159,- Euro*
2010. XXIV, 616 Seiten, Hardcover
233 Abb. (36 Farbabb.), 21 Tab.
- Handbuch/Nachschlagewerk -
ISBN-10: 3-527-31811-9
ISBN-13: 978-3-527-31811-7 - Wiley-VCH, Weinheim
Preis inkl. Mehrwertsteuer zzgl. Versandkosten.
* Serienpreis auf Anfrage bei service@wiley-vch.de
Inhalt
Probekapitel
Kurzbeschreibung
The family of aspartic acid proteases is described from a drug developer's perspective. Contains numerous case studies from recently developed protease drugs.
Aus dem Inhalt
OVERVIEW OF ASPARTIC ACID PROTEASES
Introduction to the Aspartic Proteases Family
Aspartic Acid Proteases, Structure, Function and Inhibition
Human Aspartic Proteinases
Structure-based Drug Design Strategies for the Inhibition of Aspartic Acid Proteases
HIV-1 PROTEASE FOR THE TREATMENT OF HIV/AIDS
HIV-1 Protease: Role in Viral Replication, Protein-Ligand X-ray Crystal Structures and Inhibitor Design
First generation FDA Approved HIV protease inhibitors
Second-Generation Approved HIV Protease Inhibitors for Treatment of HIV/AIDS
Design, Conception and Clinical Development of Darunavir, a HIV-1 Protease Inhibitor to Combat Drug Resistance
Development of Protease Inhibitors and Challenges to Drug-Resistance of HIV-1
RENIN FOR TREATMENT OF HYPERTENSION
Discovery and Development of Aliskiren, the First-in-Class Direct Renin Inhibitor for the Treatment of Hypertension
Evolution of Diverse Classes of Renin Inhibitors Through the Years
GAMMA-SECRETASE FOR TREATMENT OF ALZHEIMER'S DISEASE
Chemistry and Biology of gamma-Secretase as a Possible Target for Alzheimer's Disease
Gamma-Secretase Inhibition: An overview of Development of Inhibitors for Alzheimer's Disease
BETA-SECRETASE FOR TREATMENT OF ALZHEIMER'S DISEASE
BACE - An (Almost) Perfect Target for Staving Off Alzheimer's Disease
Discovery of Memapsin 2 (BACE1), Design of Inhibitors and Drug-design Tools
Peptidomimetic BACE1 Inhibitors for Treatment of Alzheimer's Disease: Design and Evolution
Non-Peptide BACE1 Inhibitors: Design and Synthesis
PLASMEPSINS AND OTHER ASPARTIC PROTEASES AS DRUG TARGETS
The Plasmepsin Family as Antimalarial Drug Targets
Design and Synthesis of Plasmepsin Inhibitors for Treatment of Malaria
Fungal aspartic proteases as possible therapeutic targets
|
|
|
|
